Kemnay Advisory Services Inc.
Position in MLYS — Mineralys Therapeutics, Inc.
CIK 1555283
New York, NY
Position in MLYS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$16,107
New position
Shares Held
597
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#186
of 224 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Kemnay Advisory Services Inc. holds $3,066,340 across 79 Biotechnology names. MLYS ranks #71 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VCEL |
Vericel Corp
|
3,903 | $173,644 | |
| 2 | FENC |
Fennec Pharmaceuticals Inc.
|
12,586 | $135,299 | |
| 3 | CYTK |
Cytokinetics Inc
|
1,164 | $99,161 | |
| 4 | KURA |
Kura Oncology, Inc.
|
8,557 | $93,870 | |
| 5 | KRYS |
Krystal Biotech, Inc.
|
232 | $86,227 | |
| 6 | PRAX |
Praxis Precision Medicines, Inc.
|
248 | $83,027 | |
| 7 | PCVX |
Vaxcyte, Inc.
|
1,299 | $75,510 | |
| 8 | TGTX |
Tg Therapeutics, Inc.
|
1,284 | $70,542 |
All Filings in MLYS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,107 | 597 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||